SNP ALLIANCE INC

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits

Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; SES (socio-economic status) issues related to SNP payment rates and quality measures; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)